Low-cost cars: opportunities and challenges

Low-cost cars: opportunities and challenges
  • Report price : $ 445
  • Publication date : April 2008
  • Length : 38 pages

Get this Report Now !

Low-cost cars: opportunities and challenges

It’s the hottest of hot topics – but it’s open to the widest of interpretations. What, exactly, is a low-cost car? The Dacia Logan, Fiat Palio, Tata Nano, Maruti 800, Lada Zhiguli? Or even a five-year-old VW Golf?

The answer is all of them. Low-cost cars are the agents of growth in the global car market. German Tier 1 supplier Bosch estimates low-cost vehicles priced below EUR 7, 000 could reach a 13% share of the world market – or about 10million vehicles – by 2010, and consultants Roland Berger estimate annual global production of 18million sub-EUR10,000 cars by 2012. The reasons are clear, as the developed world stagnates in terms of car sales, emerging markets are driving growth. Producing cars that suit the needs of consumers in these markets becomes imperative for the car industry.

That means driving down costs to the consumer – low purchase price; low running costs. And it means driving down costs for the manufacturer in order to maximise profitability. Getting this equation right is essential – there’s less room to manoeuvre with a low-cost car, and margins are inevitably slight.

Chapter 1: Introduction - A brief overview of the sector and report coverage.

Chapter 2: Legacy cars – the slow demise of the obsolete model - One of the reasons why low-cost cars are required is the need to replace ‘legacy’ cars – obsolete models that have been produced continuously in those markets for up to 40 years. These cars often define the look of the country’s roads, but the legacy cars’ days are numbered as emissions regulations and especially crash-test rules are tightened.

Chapter 3: Brazil – remake, remodel and the legacy car lives on - Brazil remains the home of the legacy car as a market-entry model. Manufacturers are unwilling to commit to spending heavily on cars in this segment – so older models are endlessly repackaged. We talk about models such as the Fiat Mille, the Peugeot 206 and the Ford Ka.

Chapter 4: Russia and India – low cost is king - In both of these markets, foreign vehiclemakers entering the market have tended to chase the more up-market sectors, with fewer sales, but higher profits. Competing with low-cost cars, which neither meet modern crash-test nor emissions standards is a challenge, and has remained a low priority.

Chapter 5: Blind alleys – the radical solutions - We take a brief look at the attempts by vehiclemakers to create concept cars that address the needs of emerging markets, through using radical manufacturing and materials technologies in order to bring down costs. Significant recent examples are the Chrysler CCV and the Fiat Ecobasic.

Chapter 6: Modern low-cost cars – how low is low? - There is no single low-cost segment, and a low-cost car is not necessarily an entry-level model. We discuss a number of specific low-cost programmes that have been defined over the years, and others that are under development. Read more about the Fiat Project 178, Renault Logan (X90), Fiat Linea, Toyota EFC and the GM low-cost car.

Chapter 7: The Indian ultra-low-cost sector and the Tata Nano - The unique dynamics of the Indian market, compared to other emerging regions, is bringing about the development of a new class of ultra-low-cost vehicles. In this chapter we discuss the Maruti low-cost project and Renault’s discussions with Indian scooter maker Bajaj regarding a joint partnership to develop a small car. Comment from Renault X90 programme Chief, Gerard Detourbet is included.

Chapter 8: Conclusions - A round up of all the key points in the report.

RELATED REPORTS

Pharmaceuticals: Global Industry Guide

Pharmaceuticals: Global Industry Guide

  • $ 1 495
  • February 2008
  • 243 pages

Datamonitor's Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading co ...

Industries : Pharmaceutical | Countries : Mexico, Brazil, Canada, USA, China, Japan, Taiwan, India, Singapore, Russia, Hungary, Poland, Czech Republic, Denmark, Norway, Sweden, Germany, Belgium, Spain, France, Italy, Netherlands, United Kingdom, Australia

OTC Pharmaceuticals: Global Industry Guide

OTC Pharmaceuticals: Global Industry Guide

  • $ 1 495
  • February 2008
  • 355 pages

Datamonitor's OTC Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the OTC pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the le ...

Industries : Pharmaceutical | Countries : Mexico, Brazil, Canada, USA, China, Japan, Taiwan, India, Singapore, Russia, Hungary, Poland, Czech Republic, Denmark, Norway, Sweden, Germany, Belgium, Spain, France, Italy, Netherlands, United Kingdom, Australia

World Weight Control Products  Market

World Weight Control Products Market

  • $ 3 950
  • March 2008
  • 438 pages

This report analyzes the worldwide markets for Weight Control Products in Millions of US$. The major product segments analyzed are Low-Fat & Fat-Free Dairy Products, Carbonated & Other Liquids, Light Foods, Prepared Intakes, Herbal Supplements, and Dressings. The report provides separate comprehensi ...

Industries : Sport and Energy Drink, Personal Care, Pharmaceutical | Countries : Brazil, Canada, USA, China, Japan, India, Thailand, Russia, Germany, Spain, France, Italy, United Kingdom, Australia

World Contraceptives Markets

World Contraceptives Markets

  • $ 3 950
  • March 2008
  • 503 pages

This report analyzes the worldwide markets for Contraceptives in Millions of US$. The specific product segments analyzed are Oral Contraceptives, Condoms, Implants/ Injections, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin Ame ...

Industries : Pharmaceutical | Countries : Egypt, Kenya, Uganda, Morocco, South Africa, Nigeria, Brazil, Colombia, Canada, USA, China, Japan, India, Pakistan, Indonesia, Croatia, Poland, Germany, France, Netherlands, United Kingdom, Switzerland, Turkey, Australia

Snapshots Brazil Pharmaceuticals 2008

Snapshots Brazil Pharmaceuticals 2008

  • $ 310
  • March 2008
  • 13 pages

Snapdata's Snapshots Brazil Pharmaceuticals 2008 provides 2007 year-end market size data, with 2008 estimates, 4 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Brazilian pharmaceutical market and covers prescription and OTC pharmaceuticals. M ...

Industries : Pharmaceutical | Countries : Brazil

Insulin Delivery Systems Market Analysis (2007-2010)

Insulin Delivery Systems Market Analysis (2007-2010)

  • $ 1 400
  • January 2008
  • 250 pages

The research report “Insulin Delivery Systems Market Analysis (2007-2010)” by RNCOS gives an exhaustive analysis on the global insulin market and various Insulin delivery methods. The report investigates the market for various devices used for delivering insulin, including syringes, pens, pumps, ...

Industries : Medical Devices, Pharmaceutical | Countries : Egypt, Mexico, Brazil, USA, China, Japan, India, Pakistan, Russia, Germany

Emerging Pharmaceutical Markets Globally

Emerging Pharmaceutical Markets Globally

  • $ 1 800
  • January 2008
  • 250 pages

The report ``Emerging Pharmaceutical Markets Globally`` provides an exhaustive overview of the pharmaceutical markets in the E7 countries (Brazil, Russia, India, China, Mexico, Turkey and Indonesia). This Report provides a detailed account of the factors that are redefining the structure and composi ...

Industries : Pharmaceutical | Countries : Mexico, Brazil, China, India, Indonesia, Russia, Turkey

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.